Remote Cellular Therapy Account Director — South Central

Pierre Fabre; United States; Remote; USD 170,000 - 250,000; Full time

Job summary

Pierre Fabre is launching a US division focused on rare diseases and oncology. We seek a strategic leader for the Cellular Therapy Director team to drive awareness, onboarding, and cross-functional execution for Tab-cel Ebvallo.

In pre-approval, you will map patient journeys, build relationships with medical and operational stakeholders, and lay the groundwork for access. Post-approval, you’ll drive utilization across institutions with a patient-centric approach.

Qualifications

• Bachelor’s degree in a relevant field.
• At least 10 years of experience in biopharma, with depth in cell or gene therapy.
• Proven ability to navigate matrixed organizations and cross-functional teams.
• Strong scientific aptitude with capacity to communicate complex treatment modalities.
• Experience selling or engaging with ultra-rare diseases, CGT preferred.

Responsibilities

• Lead disease awareness and stakeholder engagement for rare disease programs.
• Build relationships with clinical and non-clinical experts to inform patient journeys.
• Develop onboarding and launch strategies for allogeneic cell therapies.
• Drive cross-functional collaboration to support product access and utilization.
• Manage territory business plans with KPIs and targeted outcomes.

Skills

Biopharma industry experience

Cell/gene therapy knowledge

Collaborative matrix environment

Scientific aptitude

Sales experience in ultra-rare disease

Education

Bachelor's Degree

Job description

Pierre Fabre is launching a US division focused on rare diseases and oncology. We seek a strategic leader for the Cellular Therapy Director team to drive awareness, onboarding, and cross-functional execution for Tab-cel Ebvallo.

In pre-approval, you will map patient journeys, build relationships with medical and operational stakeholders, and lay the groundwork for access. Post-approval, you’ll drive utilization across institutions with a patient-centric approach.